Ruxolitinib, a JAK1/2 Inhibitor as Treatment for Paraneoplastic Pemphigus: A Case Report-MedSci.cn

Ruxolitinib, a JAK1/2 Inhibitor as Treatment for Paraneoplastic Pemphigus: A Case Report

Fan, BR; Wang, MY

Wang, MY (通讯作者)，Peking Univ First Hosp, Dept Dermatol, Beijing 100034, Peoples R China.;Wang, MY (通讯作者)，Natl Clin Res Ctr Skin & Immune Dis, Beijing, Peoples R China.;Wang, MY (通讯作者)，Beijing Key Lab Mol Diag Dermatoses, Beijing, Peoples R China.